findmyKOL
Clinical trialNCT05309694CompletedPhase 4Interventional

A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)

SponsorCooperSurgical Inc.Enrollment119Contraception
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to demonstrate that a new device inserter leads to successful and safe insertion of Paragard® IUS, comparable to the currently approved IUS inserter, in females of reproductive potential.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Downtown Women'S Healthcare

    Denver, Colorado, United States

  • South Miami Women'S Health

    South Miami, Florida, United States

  • Gyn-Care Women'S Healthcare

    Atlanta, Georgia, United States

  • Valley Ob-Gyn Clinic, Pc

    Saginaw, Michigan, United States

  • Hilltop Obstetrics & Gynecology

    Franklin, Ohio, United States

  • Austin Area Ob-Gyn & Fertility

    Austin, Texas, United States

  • Central Austin - Women Partners in Health

    Austin, Texas, United States

  • Seattle Clinical Research Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Mar 2022
Primary completion
8 Dec 2022
Completion
8 Dec 2022
Last update posted
20 Jan 2023
Registered enrollment
119
Registry id
NCT05309694

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.